7Baggers
 NeoGenomics honors Marines with leadership in security efforts  Traders Union Tue, 11 Nov 2025 16:45:21 GMT
 NeoGenomics (NEO): Assessing Value After Recent Share Price Surge  simplywall.st Fri, 07 Nov 2025 08:00:00 GMT
 NeoGenomics to Participate in Upcoming Investor Conferences  Business Wire Thu, 06 Nov 2025 12:05:00 GMT
 published on: 2025-11-05 23:13:26  newser.com Thu, 06 Nov 2025 05:13:26 GMT
 published on: 2025-11-05 05:16:52  newser.com Wed, 05 Nov 2025 11:16:52 GMT
 NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings?  Finviz Tue, 04 Nov 2025 09:11:55 GMT

NeoGenomics, Inc
(NASDAQ:NEO) 

NEO stock logo

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates in two segments, Clinical Services and Pharma Services. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceuti...

Founded: 2002
Full Time Employees: 1,700
CEO: Douglas M. Van Oort  
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends